Search research articles
Contact Us
Filters
Showing results (61-70 of 145) with videos related to
Page
of 15
Sort By:
Blood
|
August 1, 1988
The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype
S M Lippman, T P Miller, C M Spier, et al.
The Journal of Clinical Investigation
|
July 1, 1988
HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma
T P Miller, S M Lippman, C M Spier, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 1, 1987
An ultrastructural morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas
C M Payne, T M Grogan, D W Cromey, et al.
Leukemia & Lymphoma
|
August 10, 1999
The major vault protein (MVP), a new multidrug resistance associated protein, is frequently expressed in multiple myeloma
L M Rimsza, K Campbell, W S Dalton, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|
September 1, 1994
The presence of bcl-1 and bcl-2 gene rearrangements in diffuse small cleaved-cell lymphoma. A disease with diverse molecular and immunophenotypic findings
C P Leith, C L Willman, C M Spier, et al.
The American Journal of Medicine
|
November 1, 1984
Pseudonodular T cell lymphoblastic lymphoma
J E Schwartz, T M Grogan, M J Hicks, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 1, 1984
Identification of two major B cell forms of nodular mixed lymphoma
T M Grogan, M J Hicks, C S Jolley, et al.
The Journal of Infectious Diseases
|
May 1, 1989
The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis
C G Ray, T B Icenogle, L L Minnich, et al.
JAMA
|
August 11, 1978
Azathioprine-induced pure red blood cell aplasia
C W Old, E P Flannery, T M Grogan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1994
Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study
S E Salmon, J J Crowley, T M Grogan, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 145) with videos related to
Sort By:
Page
of 15
Blood
|
August 1, 1988
The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype
S M Lippman, T P Miller, C M Spier, et al.
The Journal of Clinical Investigation
|
July 1, 1988
HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma
T P Miller, S M Lippman, C M Spier, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 1, 1987
An ultrastructural morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas
C M Payne, T M Grogan, D W Cromey, et al.
Leukemia & Lymphoma
|
August 10, 1999
The major vault protein (MVP), a new multidrug resistance associated protein, is frequently expressed in multiple myeloma
L M Rimsza, K Campbell, W S Dalton, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|
September 1, 1994
The presence of bcl-1 and bcl-2 gene rearrangements in diffuse small cleaved-cell lymphoma. A disease with diverse molecular and immunophenotypic findings
C P Leith, C L Willman, C M Spier, et al.
The American Journal of Medicine
|
November 1, 1984
Pseudonodular T cell lymphoblastic lymphoma
J E Schwartz, T M Grogan, M J Hicks, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 1, 1984
Identification of two major B cell forms of nodular mixed lymphoma
T M Grogan, M J Hicks, C S Jolley, et al.
The Journal of Infectious Diseases
|
May 1, 1989
The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis
C G Ray, T B Icenogle, L L Minnich, et al.
JAMA
|
August 11, 1978
Azathioprine-induced pure red blood cell aplasia
C W Old, E P Flannery, T M Grogan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1994
Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study
S E Salmon, J J Crowley, T M Grogan, et al.
Page
of 15